XenTech is Biotech/Contract Research Organization (CRO) dedicated to translational research in oncology which offers preclinical services to evaluate the anti-cancer potential of drug candidates (PDX, CDX,...) 
In addition, XenTech develops internal R&D programs to correlate drug response with molecular features of tumors and identify cancer biomarkers and therapeutic targets.

XenTech

Office 4 at 4, rue Pierre Fontaine focuses on leading oncology studies, with a specialization in immuno-oncology research.

People (2)

Jobs (0)

Other offices